ROGER JEFFS Insider Trading $AXSM Axsome Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROGER JEFFS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROGER JEFFS. ROGER JEFFS is President & CO) in UNITED THERAPEUTICS Corp ($UTHR) and President & Co-CEO in UNITED THERAPEUTICS Corp ($UTHR) and President & COO in UNITED THERAPEUTICS Corp ($UTHR) and President 7 COO in UNITED THERAPEUTICS Corp ($UTHR) and President and COO in UNITED THERAPEUTICS Corp ($UTHR) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Director in ALBIREO PHARMA, INC. ($ALBO) and Director in Axsome Therapeutics, Inc. ($AXSM) and Director in Axovant Sciences Ltd. ($AXON) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Liquidia Corp ($LQDA).
ROGER JEFFS in Axsome Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROGER JEFFS: Director
Holdings: 65,747 shares
Current Value: $299,149
Latest Transaction: Mar 09 2021
$AXSM Market Capitalization: $85.23M
$AXSM Previous Close: $4.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROGER JEFFS in Axsome Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALBO, AXSM, DOVA, LQDA, SGMO, AXON, UTHR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 09 2021 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 65.02 | 1,463 | 95,124 | 1,463 | |
| Jun 05 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 77.38 | 13,000 | 1,005,940 | 13,000 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Mar 19 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 45.14 | 4,496 | 202,949 | 4,496 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 12.95 | 34,866 | 451,515 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 11,000 | 54,450 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 8.02 | 5,193 | 41,648 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 9.00 | 9,127 | 82,143 | 0 | |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 12.95 | 34,866 | 451,515 | 116,806 | 81.9 K to 116.8 K (+42.55 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 11,000 | 54,450 | 81,940 | 70.9 K to 81.9 K (+15.51 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 8.02 | 5,193 | 41,648 | 70,940 | 65.7 K to 70.9 K (+7.90 %) |
| Jan 14 2020 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 9.00 | 9,127 | 82,143 | 65,747 | 56.6 K to 65.7 K (+16.12 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.45 | 13,000 | 44,850 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 2.85 | 39,948 | 113,852 | 0 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 3,672 | 13,476 | 7,344 | |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.45 | 13,000 | 44,850 | 56,620 | 43.6 K to 56.6 K (+29.80 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 2.85 | 39,948 | 113,852 | 43,620 | 3.7 K to 43.6 K (+1,087.91 %) |
| Jul 05 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 3,672 | 13,476 | 3,672 | 0 to 3.7 K |
| Jun 10 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 22.03 | 13,000 | 286,390 | 13,000 | |
| Mar 21 2019 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 12.95 | 34,866 | 451,515 | 34,866 | |
| Jun 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 3.45 | 13,000 | 44,850 | 13,000 | |
| Apr 05 2018 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 2.85 | 39,948 | 113,852 | 39,948 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 4.95 | 35,194 | 174,210 | 0 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | M | 3.67 | 7,344 | 26,952 | 3,672 | |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 4.95 | 35,194 | 174,210 | 46,912 | 11.7 K to 46.9 K (+300.34 %) |
| Mar 30 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | M | 3.67 | 7,344 | 26,952 | 11,718 | 4.4 K to 11.7 K (+167.90 %) |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 11,000 | 54,450 | 11,000 | |
| Mar 17 2017 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 4.95 | 35,194 | 174,210 | 35,194 | |
| Jun 01 2016 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 8.02 | 5,193 | 41,648 | 5,193 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 5.94 | 4,374 | 25,982 | 0 | |
| Nov 24 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Buy | C | 5.94 | 4,374 | 25,982 | 4,374 | 0 to 4.4 K |
| Nov 23 2015 | AXSM | Axsome Therapeutic ... | JEFFS ROGER | Director | Option Exercise | A | 9.00 | 9,127 | 82,143 | 9,127 |
Page: 1